Remove Communication Remove Diabetes Remove HIPAA
article thumbnail

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

pharmaphorum

You may ask: Can an open protocol be HIPAA compliant? HIPAA does not specifically prohibit using and sharing open protocol-based software. Their patient journey typically requires engaging with discrete service providers, who are often using antiquated means of communication. The time to cross that bridge has passed.

HIPAA 98
article thumbnail

Top Clinical Services for Boosting Your Pharmacy’s Revenue

Digital Pharmacist

Chronic Disease Management Independent pharmacies can play a crucial role in managing chronic diseases such as diabetes, hypertension, and asthma. Pharmacy teams can communicate with their patients via HIPAA-complaint, secure messages thus reducing time on the phone and increasing efficiency within the pharmacy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

7 Ways To Improve Medication Adherence and Lower DIR Fees

Digital Pharmacist

Pharmacy Performance Metrics Medication Adherence: Non-adherence to three chronic disease categories — oral diabetes medications, statins for cholesterol, and hypertension medications — impacts a pharmacy’s adherence score. To comply, pharmacies need to coordinate with doctors to get statins prescribed to patients with diabetes.

article thumbnail

Healthcare Email Marketing Strategies: A Guide for Pharma Executives

Pharma Marketing Network

In an industry as specialized as healthcare, personalized communication can make or break your relationship with HCPs and patients. Staying compliant with regulations like HIPAA and GDPR is non-negotiable. Here’s a quick look at a successful email campaign in pharma: Objective : Increase awareness about a new diabetes drug.

HIPAA 52
article thumbnail

Audience Targeting in Pharma Marketing: Reaching the Right Patients and Providers

Pharma Marketing Network

For instance, targeting a diabetes drug like Jardiance involves identifying adults struggling with Type 2 diabetes and tailoring messages about improved glycemic control. Solution: Partner with legal and compliance teams to ensure all campaigns adhere to FDA and HIPAA guidelines.

HIPAA 52
article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

As noted in our previous communications, while the NHC would prefer a more traditional Notice and Comment rulemaking opportunity that would ensure the Agency directly responds to stakeholder feedback, we welcome this opportunity to express our reactions to CMS’ thinking on the negotiation program.

article thumbnail

A digital twin for the body: why patient data consent is vital

Pharmaceutical Technology

You might have someone's weight, height, what they have eaten this week, their resting heart rate,” says Katherine Pomfret, head of communications at Syrenis. At this year’s American Diabetes Association annual scientific session, clinical trial data was presented that analysed 199 diabetes patients for an average of four years.